These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7842431)

  • 1. Early diagnosis of optic glioma in children with neurofibromatosis type 1.
    Rossi LN; Pastorino G; Scotti G; Gazocchi M; Maninetti MM; Zanolini C; Chiodi A
    Childs Nerv Syst; 1994 Sep; 10(7):426-9. PubMed ID: 7842431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
    Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
    Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials.
    North K; Cochineas C; Tang E; Fagan E
    Pediatr Neurol; 1994 Mar; 10(2):117-23. PubMed ID: 8024659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optic gliomas in children with neurofibromatosis type 1.
    Lund AM; Skovby F
    Eur J Pediatr; 1991 Oct; 150(12):835-8. PubMed ID: 1743214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?
    Wolsey DH; Larson SA; Creel D; Hoffman R
    J AAPOS; 2006 Aug; 10(4):307-11. PubMed ID: 16935228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
    Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ
    Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance findings and ophthalmologic abnormalities are correlated in patients with neurofibromatosis type 1 (NF1).
    Sigorini M; Zuccoli G; Ferrozzi F; Bacchini E; Street ME; Piazza P; Rossi M; Virdis R
    Am J Med Genet; 2000 Aug; 93(4):269-72. PubMed ID: 10946351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual-evoked potentials in the assessment of optic gliomas.
    Ng YT; North KN
    Pediatr Neurol; 2001 Jan; 24(1):44-8. PubMed ID: 11182280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optic gliomas in children with neurofibromatosis type 1.
    Listernick R; Charrow J; Greenwald MJ; Esterly NB
    J Pediatr; 1989 May; 114(5):788-92. PubMed ID: 2497236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optic pathway gliomas in children with and without neurofibromatosis 1.
    Czyzyk E; Jóźwiak S; Roszkowski M; Schwartz RA
    J Child Neurol; 2003 Jul; 18(7):471-8. PubMed ID: 12940652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optic nerve glioma and cerebellar astrocytoma in a patient with von Recklinghausen's neurofibromatosis.
    Miller NR
    Am J Ophthalmol; 1975 Apr; 79(4):582-8. PubMed ID: 804254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pattern visual-evoked potentials to perimetry in the detection of visual loss in children with optic pathway gliomas.
    Kelly JP; Weiss AH
    J AAPOS; 2006 Aug; 10(4):298-306. PubMed ID: 16935227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial visual pathway gliomas in children with neurofibromatosis.
    Packer RJ; Bilaniuk LT; Cohen BH; Braffman BH; Obringer AC; Zimmerman RA; Siegel KR; Sutton LN; Savino PJ; Zackai EH
    Neurofibromatosis; 1988; 1(4):212-22. PubMed ID: 3152473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comments on neurofibromatosis 1 and optic pathway tumors.
    Listernick R; Charrow J; Gutmann DH
    Am J Med Genet; 2001 Jul; 102(1):105. PubMed ID: 11471182
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.
    Chang BC; Mirabella G; Yagev R; Banh M; Mezer E; Parkin PC; Westall CA; Buncic JR
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.
    Dotto PF; Berezovsky A; Cappellano AM; da Silva NS; Sacai PY; Silva FAB; Fernandes AG; Rocha DM; Salomão SR
    Doc Ophthalmol; 2018 Jun; 136(3):177-189. PubMed ID: 29766345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glioma of the optic chiasma and nerve. Contribution of transcutaneous radiotherapy to their treatment].
    Throuvalas N; Bataini P; Ennuyer A
    Bull Cancer; 1969; 56(3):231-64. PubMed ID: 4994731
    [No Abstract]   [Full Text] [Related]  

  • 18. Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions?
    Aquilina K; Daniels DJ; Spoudeas H; Phipps K; Gan HW; Boop FA
    Childs Nerv Syst; 2015 Nov; 31(11):2041-9. PubMed ID: 26277358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
    Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging.
    Balcer LJ; Liu GT; Heller G; Bilaniuk L; Volpe NJ; Galetta SL; Molloy PT; Phillips PC; Janss AJ; Vaughn S; Maguire MG
    Am J Ophthalmol; 2001 Apr; 131(4):442-5. PubMed ID: 11292406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.